NCT01347892

Brief Summary

The purpose of this post-market clinical study is to collect long-term outcomes for DeNovo NT Graft treatment of articular cartilage lesions in the ankle in a standard clinical setting. Outcomes to be assessed include pain, function, activity levels and healthcare resource use.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
205

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2011

Longer than P75 for all trials

Geographic Reach
1 country

8 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2011

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

January 26, 2017

Status Verified

January 1, 2017

Enrollment Period

8.3 years

First QC Date

May 3, 2011

Last Update Submit

January 25, 2017

Conditions

Keywords

Talar injuryanklelesiondefectcartilage repair

Outcome Measures

Primary Outcomes (1)

  • Mean scores from patient-reported clinical outcome surveys

    5 years

Secondary Outcomes (1)

  • Incidence of reoperations and revision surgeries

    5 years

Study Arms (1)

DeNovo NT Subject

Subjects who have received or who are scheduled to receive a DeNovo NT Graft for repair of a cartilage lesion in the ankle.

Other: DeNovo NT Natural Tissue Graft

Interventions

DeNovo NT is a juvenile cartilagenous tissue graft, inclusive of a viable human cartilage cells. It is provided as particulated tissue pieces of approximately 1mm3 each

Also known as: DeNovo NT
DeNovo NT Subject

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects who have received or who are scheduled to receive a DeNovo NT graft for repair of a cartilage lesion in the ankle.

You may not qualify if:

  • Has an articular cartilage lesion(s) in the ankle for which arthroscopic or surgical intervention with DeNovo NT Graft is warranted or has had prior treatment with DeNovo NT Graft for an articular cartilage lesion(s) in the ankle
  • Has voluntarily signed the IRB approved informed consent
  • Is of stable health and is able to undergo surgery
  • Is male or female over the age of 18 at the time of consent
  • Is physically and mentally willing and able to comply with post-operative rehabilitation and routinely scheduled clinical visits.
  • Displays a high surgical risk as determined by the investigative surgeon
  • Is pregnant or breast-feeding
  • Has a clinically diagnosed autoimmune disease
  • Has an active joint infection or history of chronic joint infection at the surgical site
  • Has medical history that would likely make the subject unreliable for the study, or any combination of variables in the investigator's judgment that should exclude a potential subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University of California, Davis at UC Davis Medical Center

Sacramento, California, 95817, United States

Location

Tripler Army Medical Center

Honolulu, Hawaii, 96859, United States

Location

MedStar Health Research Institute at Union Memorial Hospital

Baltimore, Maryland, 21218, United States

Location

Minnesota Orthopedic Sports Medicine Institue at Twin Cities Orthopedics

Edina, Minnesota, 55435, United States

Location

OhioHealth Research Institute at Orthopedic Foot & Ankle Center

Westerville, Ohio, 43082, United States

Location

San Antonio Military Medical Center/Brooke Army Medical Center

Fort Sam Houston, Texas, 78248, United States

Location

The Orthopaedic Foot & Ankle Center of Washington

Falls Church, Virginia, 22042, United States

Location

Madigan Army Medical Center

Tacoma, Washington, 98431, United States

Location

Related Publications (1)

  • Coetzee JC, Giza E, Schon LC, Berlet GC, Neufeld S, Stone RM, Wilson EL. Treatment of osteochondral lesions of the talus with particulated juvenile cartilage. Foot Ankle Int. 2013 Sep;34(9):1205-11. doi: 10.1177/1071100713485739. Epub 2013 Apr 10.

MeSH Terms

Conditions

Osteochondritis Dissecans

Condition Hierarchy (Ancestors)

OsteochondritisBone DiseasesMusculoskeletal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2011

First Posted

May 5, 2011

Study Start

March 1, 2011

Primary Completion

July 1, 2019

Study Completion

September 1, 2019

Last Updated

January 26, 2017

Record last verified: 2017-01

Locations